Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate human T cells

We tried to purify a substance exhibiting mitogenicity for human peripheral blood lymphocytes from Yersinia pseudotuberculosis isolated from patients with Y. pseudotuberculosis infection manifesting acute and systemic clinical symptoms. The supernatant of a suspension of the bacteria disrupted by sonication was serially chromatographed on DEAE-Sepharose fast-flow, Sephacryl S-100 HR, and TSK-gel G2000SW high-pressure liquid chromatography columns. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis revealed that the purified mitogenically active substance migrated as a single band corresponding to a molecular mass of 21 kDa. We designated the purified substance Y. pseudotuberculosis-derived mitogen (YPM). YPM stimulated human peripheral T cells to proliferate and produce interleukin-2 at 0.1 ng/ml or more. YPM-induced T-cell activation required the expression of HLA class II molecules on accessory cells.

[1]  J. Woodward,et al.  Yersinia enterocolitica produces superantigenic activity. , 1992, Journal of immunology.

[2]  H. Inoko,et al.  Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin , 1990, Infection and immunity.

[3]  P. Marrack,et al.  The staphylococcal enterotoxins and their relatives. , 1990, Science.

[4]  T. Tadakuma,et al.  Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules. , 1989, Journal of immunology.

[5]  H. Inoko,et al.  Activation of human t cells by toxic shock syndrome toxin‐1: the toxin‐binding structures expressed on human lymphoid cells acting as accessory cells are hla class ii molecules , 1989, European journal of immunology.

[6]  P. Schlievert,et al.  Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. , 1987, The New England journal of medicine.

[7]  X. Yan,et al.  Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin. , 1987, Clinical and experimental immunology.

[8]  L. Graves,et al.  Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins. , 1985, JAMA.

[9]  P. J. Barcia,et al.  Scarlatiniform rash and pleural effusion in a patient with Yersinia pseudotuberculosis infection. , 1983, The Journal of pediatrics.

[10]  M. Taki,et al.  Yersinia pseudotuberculosis infection in children, resembling Izumi fever and Kawasaki syndrome , 1983, Pediatric infectious disease.

[11]  M. Bergdoll,et al.  A NEW STAPHYLOCOCCAL ENTEROTOXIN, ENTEROTOXIN F, ASSOCIATED WITH TOXIC-SHOCK-SYNDROME STAPHYLOCOCCUS AUREUS ISOLATES , 1981, The Lancet.

[12]  G. Schmid,et al.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. , 1981, The Journal of infectious diseases.

[13]  G. Schmid,et al.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. , 1980, The New England journal of medicine.

[14]  T. Segawa,et al.  The enzymes of the galactose cluster in Saccharomyces cerevisiae. Purification and characterization of galactose-1-phosphate uridylyltransferase. , 1979, The Journal of biological chemistry.

[15]  T. Maruyama,et al.  [Large scale outbreak of Yersinia pseudotuberculosis serotype 5a infection at Noheji-machi in Aomori Prefecture]. , 1993, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[16]  X. Yan,et al.  Activation of human vascular endothelial cells by IFN-gamma: acquisition of HLA class II expression, TSST-1-binding activity and accessory activity in T cell activation by the toxin. , 1991, International archives of allergy and applied immunology.

[17]  P. Marrack,et al.  Superantigens: mechanism of T-cell stimulation and role in immune responses. , 1991, Annual review of immunology.